In phase III: Semaglutide 2.4 mg (STEP-1): nausea 44.2%, diarrhea 31.5%, vomiting 24.8% Tirzepatide 15 mg (SURMOUNT-1): nausea 29.2%, diarrhea 23.0%, constipation 16.8% Retatrutide 12 mg (TRIUMPH-1): nausea 37.2%, vomiting 22.0%, diarrhea 27.1% Key observation: tirzepatide shows the most favorable GI profile at equivalent dose, likely tied to the GIP component dampening GLP-1-mediated nausea signaling at the brainstem level
You need to change your behavior and mindset. Demi, now 60 pounds lighter, says losing those self-loathing thoughts has been the biggest weight off of her shoulders
& Van Tongeren, J
Niacinamide A form of vitamin B3 that inhibits the transfer of melanosomes to the skin cells
Many patients also spend more time looking down at mobile devices or hunching forward at work, habits that intensify neck strain during periods of significant body change
Improved Gut Health This may aid conditions like ulcers and inflammatory bowel diseases